摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R)-8-methoxy-3,4-dihydro-2H-chromen-3-amine | 164322-65-0

中文名称
——
中文别名
——
英文名称
(3R)-8-methoxy-3,4-dihydro-2H-chromen-3-amine
英文别名
——
(3R)-8-methoxy-3,4-dihydro-2H-chromen-3-amine化学式
CAS
164322-65-0
化学式
C10H13NO2
mdl
MFCD09026807
分子量
179.219
InChiKey
YPFAOXHRMCVHOP-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    299.3±40.0 °C(Predicted)
  • 密度:
    1.128±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    44.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3R)-8-methoxy-3,4-dihydro-2H-chromen-3-amine三氟二甲基硫醚络合物 、 montmorillonite K-10 、 sodium cyanoborohydride 作用下, 生成 (3R)-3-(dipropylamino)-3,4-dihydro-2H-chromen-8-ol
    参考文献:
    名称:
    Novel 2-Aminotetralin and 3-AminoChroman Derivatives as Selective Serotonin 5-HT7 Receptor Agonists and Antagonists
    摘要:
    The understanding of the physiological role of the G-protein coupled serotonin 5-HT7 receptor is largely rudimentary. Therefore, selective and potent pharmacological tools will add to the understanding of serotonergic effects mediated through this receptor. In this report, we describe two compound classes, chromans and tetralins, encompassing compounds with nanomolar affinity for the 5-HT7 receptor and with good selectivity. Within theses classes, we have discovered both agonists and antagonists that can be used for further understanding of the pharmacology of the 5-HT7 receptor.
    DOI:
    10.1021/jm0498102
  • 作为产物:
    描述:
    8-甲氧基-2H-苯并吡喃-3-甲腈盐酸sodium hydroxide 、 palladium on activated charcoal 、 叠氮磷酸二苯酯甲酸铵 、 sodium cyanoborohydride 、 potassium carbonate溶剂黄146三乙胺 、 potassium iodide 作用下, 生成 (3R)-8-methoxy-3,4-dihydro-2H-chromen-3-amine
    参考文献:
    名称:
    Novel 2-Aminotetralin and 3-AminoChroman Derivatives as Selective Serotonin 5-HT7 Receptor Agonists and Antagonists
    摘要:
    The understanding of the physiological role of the G-protein coupled serotonin 5-HT7 receptor is largely rudimentary. Therefore, selective and potent pharmacological tools will add to the understanding of serotonergic effects mediated through this receptor. In this report, we describe two compound classes, chromans and tetralins, encompassing compounds with nanomolar affinity for the 5-HT7 receptor and with good selectivity. Within theses classes, we have discovered both agonists and antagonists that can be used for further understanding of the pharmacology of the 5-HT7 receptor.
    DOI:
    10.1021/jm0498102
点击查看最新优质反应信息

文献信息

  • DERIVATIVES OF BENZOPYRAN AND OF BENZOTHIOPYRAN, THEIR PREPARATION AND THEIR USE AS AGONISTS OF DOPAMINERGIC RECEPTORS
    申请人:ZAMBON GROUP S.p.A.
    公开号:EP0781280B1
    公开(公告)日:2002-11-06
  • [EN] DERIVATIVES OF BENZOPYRAN AND OF BENZOTHIOPYRAN, THEIR PREPARATION AND THEIR USE AS AGONISTS OF DOPAMINERGIC RECEPTORS<br/>[FR] DERIVES DE BENZOPYRANE ET DE BENZOTHIOPYRANE, LEUR PREPARATION AINSI QUE LEUR UTILISATION EN TANT QU'AGONISTES DES RECEPTEURS DOPAMINERGIQUES
    申请人:ZAMBON GROUP S.P.A.
    公开号:WO1996008489A1
    公开(公告)日:1996-03-21
    (EN) Compounds of formula (I), wherein R, R', R', Z, m, Y, n, R1, X, p and Ar have the meanings reported in the description; and pharmaceutically acceptable salts thereof are described. The compounds of formula (I) are useful in the treament of arterial hypertension and heart failure, of renal failure, of peripheral arteriopathies, of cerebrovascular insufficiencies and of ischemic cardiopathy.(FR) Composés de la formule (I), ainsi que leurs sels acceptables sur le plan pharmacologique, formule dans laquelle R, R', R', Z, m, Y, n, R1, X, p et Ar ont les notations données dans la description. Les composés de la formule (I) sont utiles dans le traitement de l'hypertension artérielle et de l'insuffisance cardiaque, de l'insuffisance rénale, des artériopathies périphériques, des insuffisances vasculaires cérébrales ainsi que de la cardiopathie ischémique.
查看更多